Halt wins finance for commercialization of Acessa system

Halt Medical has obtained $15m finance from American Capital to support the commercialization of its Acessa system, designed for treating uterine fibroids.

See the original article here:
Halt wins finance for commercialization of Acessa system

Tags: commercialization, fibroids, halt, medical, qd syringe systems, qd-syringe, quick draw syringe, result, Syringes, uterine

This entry was posted on Wednesday, January 2nd, 2013 at 11:55 am by admin and is filed under Needlestick Statistics, Syringes. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.